Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ambulatory Surgery Centers
Providers
Industry Voices—CMS need better safeguards for IPO List removal
The proposal to phase out the Inpatient Only List rule lacks a mechanism to track any potential increase in complications, readmissions or deaths.
Lee Fleisher, M.D.
,
Nancy Foster
Aug 22, 2025 10:45am
Armed with pricing data, employers may confront legal burden
Aug 18, 2025 8:00am
Ascension makes AmSurg acquisition rumors official
Jun 17, 2025 12:15pm
Ascension nears $3.9B AmSurg purchase: Bloomberg
Jun 2, 2025 11:30am
Ardent Health on the lookout for deals following solid Q1
May 7, 2025 5:00pm
Tenet overperforms in Q1, will stay aggressive amid headwinds
Apr 29, 2025 3:20pm
